All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Denocad 6mg Injection
Prescription Required
Salt Composition : Denosumab
Manufacturer : CADILA PHARMACEUTICALS LTD
Origin of Medicine : India
1 Vial(s)
Introduction to Denocad 6mg Injection
Denocad 6mg Injection containing active ingredient Denosumab should not be used in individuals with known hypersensitivity or allergic reactions to its components. Adequate calcium and vitamin D supplementation is required during treatment to maintain optimal bone health. It is not approved for use in children and adolescents. Its safety and effectiveness in pediatric populations have not been established, so its use is contraindicated in individuals under 18. This medication should be used cautiously in individuals with pre-existing hypoparathyroidism, characterized by low parathyroid hormone levels.
Uses of Denocad 6mg Injection
Denocad 6mg Injection is used in the treatment of the following conditions:
- Osteoporosis
- Bone loss due to hormonal therapy in breast or prostate cancer
- Multiple myeloma (cancer affecting plasma cells in the bone marrow)
- Bone metastases (cancer that spreads to bone)
Therapeutic Effects of Denocad 6mg Injection
Denocad 6mg Injection has therapeutic effects that include reducing fracture risk, increasing bone mineral density, and improving overall bone health. By inhibiting bone resorption through its action on RANK ligands, this medication strengthens bones and decreases the likelihood of fractures in individuals with osteoporosis or those at high risk. It also increases bone mineral density, an important marker of bone strength. These therapeutic effects contribute to improved bone health and a reduced risk of fractures, ultimately enhancing the quality of life for patients.
Interaction of Denocad 6mg Injection with other drugs
Inform your doctor about all medications, including prescription drugs, over-the-counter medications, nutritional supplements, and herbal products. Certain medications may interact with Denocad 6mg Injection and reduce its effectiveness or cause undesirable side effects.
More Information about Denocad 6mg Injection
Denocad 6mg Injection should be stored as follows:
- In the refrigerator at a temperature between 2°C to 8°C (36°F to 46°F)
- Do not freeze it.
- Keep it in the original package.
- Protect from light, moisture, and heat.
- Keep it out of reach of children and pets.
- Avoid taking double doses for missed doses.
How to consume Denocad 6mg Injection
Denocad 6mg Injection is administered as an injection by healthcare professionals. The dosage and duration of treatment will depend on the individual's condition and response to the medication, as determined by a healthcare provider.
Safety Advices for Denocad 6mg Injection
Pregnancy
The safety of using Denocad 6mg Injection during pregnancy has not been established. Limited studies are available regarding its use in pregnant women, so caution and consultation with a doctor are essential.
Breast Feeding
It is unknown whether Denocad 6mg Injection is excreted in breast milk. Breastfeeding mothers should consult a healthcare provider before taking this medication.
Lungs
If you have a history of lung or respiratory disorders, consult your healthcare provider before taking Denocad 6mg Injection.
Liver
Denocad 6mg Injection is primarily metabolized in the liver. Its safety has not been extensively studied in individuals with severe liver impairment. Communicate any pre-existing liver conditions to your healthcare provider to ensure safe use.
Alcohol
Avoid or limit alcohol consumption while taking Denocad 6mg Injection, as it may increase the risk of side effects.
Driving
Patients receiving Denocad 6mg Injection should avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision.
Side Effects of Denocad 6mg Injection
Like all medications, Denocad 6mg Injection can cause side effects, although not everyone may experience them.
Serious Side Effects:
- Osteonecrosis of the jaw (severe necrosis or death of jaw cells)
- Atypical femoral fractures
- Hypocalcemia (low blood calcium levels)
Common Side Effects:
- Injection site reactions
- Back pain
- Musculoskeletal pain
- Infections
- Abdominal pain
- Headache
- Hypophosphatemia (low blood phosphate levels)
Word of Advice
Attend all scheduled appointments and follow-up visits to monitor your response to Denocad 6mg Injection and address any concerns or side effects. Inform your doctor about your medical history, especially if you have previous infections, liver disease, or kidney disease. Seek immediate medical attention if you experience severe allergic reactions or other serious side effects. Additionally, Denocad 6mg Injection may affect calcium levels, so ensure adequate calcium and vitamin D intake. Pregnant and breastfeeding women should consult a doctor before taking this medication. Avoid taking any vaccines during treatment.
FAQs
Q 1. Can Denocad 6mg Injection be used in patients with a history of cancer?
Yes, Denocad 6mg Injection is used in conditions like multiple myeloma or bone metastases. It is important to discuss your medical history and any previous or current cancer diagnoses with your healthcare provider before starting this medication.
Q 2. Can Denocad 6mg Injection be used in patients with kidney problems?
Caution is advised for patients with severe renal impairment or end-stage renal disease. Your healthcare provider will assess the potential risks and benefits based on your renal function.
Q 3. Can Denocad 6mg Injection be used as a treatment for osteoporosis in men?
Yes, Denocad 6mg Injection is approved for the treatment of osteoporosis in men at increased risk of fractures.
Q 4. Can Denocad 6mg Injection be used in individuals with dental implants?
Using Denocad 6mg Injection may slightly increase the risk of jaw osteonecrosis. Discuss your dental history with your healthcare provider before starting this medication.
Fact Box of Denocad 6mg Injection
Molecule name: Denosumab | Therapeutic class: Anti-resorptive agent |
| Pharmacological class: Monoclonal Antibodies | Indications: 1. Osteoporosis 2. Bone loss due to hormonal therapy in breast or prostate cancer 3. Multiple myeloma 4. Bone metastases
|
References
- Amgen Ltd, Electronic medicines compendium (EMC), [ Revised on 13th May 2023], [ Accessed on 31st May 2023],https://www.medicines.org.uk/emc/files/pil.568.pdf
- Amgen Manufacturing Limited, US Food and Drug Administration, [ Revised on November 2010] [ Accessed on 31st May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125320s007lbl.pdf
- Amgen Manufacturing Limited, US Food and Drug Administration, [ Revised on November 2022] [ Accessed on 31st May 2023], https://www.fda.gov/media/163378/download
Disclaimer
MrMed’s primary intention is to ensure that its consumers get accurate and trustworthy information that is reviewed by experts. The contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
